Read + Share
Amedeo Smart
Independent Medical Education
Chirumbolo S. May the concurrent use of indomethacin and an anti-oxidant in the SARS-CoV2 infection treatment induce an exacerbation of COVID-19? J Med Virol 2022 May 18. doi: 10.1002/jmv.27868.PMID: 35585007
Email
LinkedIn
Facebook
Twitter
Privacy Policy